Skip to Main Content
ADVERTISEMENT
SCROLL TO CONTINUE WITH CONTENT



Property Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes
Advertisement
Journal of Investigative Dermatology Home
Close
  • Home
  • Articles & Issues
    • Back
    • Articles In Press
    • Current Issue
    • List of Issues
    • Meeting Abstracts
    • Supplements
  • Authors
    • Back
    • About Open Access
    • Submit a Manuscript 
    • Welcome, Authors!
    • Information for Authors
    • Information for Authors - PDF Download 
    • Contact the Editorial Office
    • Permissions
  • Reviewers
    • Back
    • Information for Reviewers
    • Reviewer Login 
  • Journal Info
    • Back
    • About the Journal
    • About Open Access
    • Contact the Editorial Office
    • Editorial Board
    • Abstracting/Indexing
    • Access Instructions
    • New Content Alerts
    • Submit a Manuscript 
    • Why Publish in JID?
  • Collections
    • Back
    • Atopic Dermatitis
    • Cover Gallery
    • Itch
    • JAAD / JID Junction
    • Landmarks in Cutaneous Biology
    • Melanoma
    • Methods and Techniques for Skin Research
    • Montagna Symposium on the Biology of Skin
    • Pemphigus and Pemphigoid
    • Progress in Translational Research
    • Psoriasis
    • Resources for Clinical Research in the JID
  • News
    • Back
    • Society/Journal News
  • Advertisers 
  • SID
    • Back
    • SID Member Activation 
    • SID Website 
    • Join SID 
    • Annual Meeting 
    • Academic Industry Partnership 
  • ESDR
    • Back
    • ESDR Website 
    • Join ESDR 
    • Awards 
    • Events 
    • Media 
    • Education 
  • JAAD / JID Junction
  • Companion Titles
    • Back
    • Journal of Investigative Dermatology Symposium Proceedings
    • JID Innovations
Advanced searchSave search

Please enter a term before submitting your search.

Ok
  • Submit
  • Log in
  • Register
  • Log in
    • Submit
    • Log in
  • Subscribe
  • Claim
Skip menu
    x

    Filter:

    Filters applied

    • Melanoma
    • MITFRemove MITF filter
    Clear all

    Article Type

    • Research Article2
    • Rapid Communication1

    Publication Date

    Author

    • Bechadergue, Audrey1
    • Bonaventure, Jacky1
    • Domingues, Melanie1
    • Gros, Gwendoline1
    • Han, Jae Ho1
    • Jönsson, Göran1
    • Kang, Hee Young1
    • Kim, Jang-Hee1
    • Kim, Misun1
    • Larue, Lionel1
    • Lauss, Martin1
    • Luciani, Flavie1
    • Marine, Jean-Christophe1
    • Meurice, Guillaume1
    • Newton-Bishop, Julia1
    • Nsengimana, Jeremie1
    • Park, Tae Jun1
    • Rambow, Florian1
    • Staaf, Johan1

    Journal

    • Journal of Investigative Dermatology3

    Keyword

    • microphthalmia-associated transcription factor3
    • TCGA2
    • LEF1
    • lymphoid enhancer-binding factor1
    • microRNA1
    • miR1
    • miRNA1
    • NEDD91
    • neural precursor cell expressed developmentally down-regulated protein 91
    • NHEM1
    • normal human epidermal melanocytes1
    • secreted frizzled-related protein 21
    • sFRP21
    • T cell factor1
    • TCF1
    • TCF41
    • The Cancer Genome Atlas1
    • The Cancer Genome Atlas network1
    • transcription factor 41

    Access Filter

    • Open Access

    Melanoma

    3 Results
    Subscribe to collection
    • Export
      • PDF
      • Citation

    Please select at least one article in order to proceed.

    Ok
    FilterHide Filter
    • Letter to the Editor
      Open Access

      Consensus of Melanoma Gene Expression Subtypes Converges on Biological Entities

      Journal of Investigative Dermatology
      Vol. 136Issue 12p2502–2505Published online: June 23, 2016
      • Martin Lauss
      • Jeremie Nsengimana
      • Johan Staaf
      • Julia Newton-Bishop
      • Göran Jönsson
      Cited in Scopus: 20
      • Preview Hide Preview
      • Download PDF
      • Export Citation
        Identification of recurrent mutation in the BRAF oncogene in melanoma has led to the development of highly selective kinase inhibitors (Larkin et al., 2014). Although dramatic treatment responses are initially observed, responses are rarely durable. The mutational classification based on BRAF, NRAS, and NF1 mutations that has been established, however, is nonoverlapping with classification derived from gene expression profiling (The Cancer Genome Atlas Network [TCGA], 2015; Jönsson et al., 2010).
        Consensus of Melanoma Gene Expression Subtypes Converges on Biological Entities
      • Original Article Melanocytes/Melanoma
        Open Archive

        Regulation of Melanoma Progression through the TCF4/miR-125b/NEDD9 Cascade

        Journal of Investigative Dermatology
        Vol. 136Issue 6p1229–1237Published online: March 8, 2016
        • Florian Rambow
        • Audrey Bechadergue
        • Flavie Luciani
        • Gwendoline Gros
        • Melanie Domingues
        • Jacky Bonaventure
        • and others
        Cited in Scopus: 21
        • Preview Hide Preview
        • Download PDF
        • Export Citation
          Melanoma progression from a primary lesion to a distant metastasis is a complex process associated with genetic alterations, epigenetic modifications, and phenotypic switches. Elucidation of these phenomena may indicate how to interfere with this fatal disease. The role of microRNAs as key negative regulators of gene expression, controlling all cellular processes including cell migration and invasion, is now being recognized. Here, we used in silico analysis of microRNA expression profiles of primary and metastatic melanomas and functional experiments to show that microRNA-125b (miR-125b) is a determinant candidate of melanoma progression: (i) miR-125b is more strongly expressed in aggressive metastatic than primary melanomas, (ii) there is an inverse correlation between the amount of miR-125b and overall patient survival, (iii) invasion/migration potentials in vitro are inversely correlated with the amount of miR-125b in a series of human melanoma cell lines, and (iv) inhibition of miR-125b reduces migratory and invasive potentials without affecting cell proliferation in vitro.
          Regulation of Melanoma Progression through the TCF4/miR-125b/NEDD9 Cascade
        • Original Article Melanocytes/Melanoma
          Open Archive

          Secreted Frizzled-Related Protein 2 (sFRP2) Functions as a Melanogenic Stimulator; the Role of sFRP2 in UV-Induced Hyperpigmentary Disorders

          Journal of Investigative Dermatology
          Vol. 136Issue 1p236–244Published in issue: January, 2016
          • Misun Kim
          • Jae Ho Han
          • Jang-Hee Kim
          • Tae Jun Park
          • Hee Young Kang
          Cited in Scopus: 36
          • Preview Hide Preview
          • Download PDF
          • Export Citation
            In this study, we found that secreted frizzled-related protein 2 (sFRP2) is overexpressed in the hyperpigmentary skin of melasma and solar lentigo and in acutely UV-irradiated skin. To investigate the effect of sFRP2 on melanogenesis, normal human melanocytes were infected with sFRP2-lentivirus or sh-sFRP2. It was found that sFRP2 stimulates melanogenesis through microphthalmia-associated transcription factor and/or tyrosinase upregulation via β-catenin signaling. The stimulatory action of sFRP2 in pigmentation was further confirmed in melanocytes cocultured with fibroblasts and in ex vivo cultured skin.
            Secreted Frizzled-Related Protein 2 (sFRP2) Functions as a Melanogenic Stimulator; the Role of sFRP2 in UV-Induced Hyperpigmentary Disorders
          Page 1 of 1

          Login to your account

          Show
          Forgot password?
          Don’t have an account?
          Create a Free Account

          If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password

          If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password

          Cancel
          • Home
          • Articles & Issues
          • Articles In Press
          • Current Issue
          • List of Issues
          • Meeting Abstracts
          • Supplements
          • Authors
          • About Open Access
          • Submit a Manuscript
          • Welcome, Authors!
          • Information for Authors
          • Information for Authors - PDF Download
          • Contact
          • Permissions
          • Reviewers
          • Information for Reviewers
          • Reviewer Login
          • Journal Info
          • About the Journal
          • About Open Access
          • Contact the Editorial Office
          • Editorial Board
          • Abstracting/Indexing
          • Access Instructions
          • New Content Alerts
          • Submit a Manuscript
          • Why Publish in JID?
          • Collections
          • Atopic Dermatitis
          • Cover Gallery
          • Itch
          • JAAD / JID Junction
          • Landmarks in Cutaneous Biology
          • Melanoma
          • Methods and Techniques for Skin Research
          • Montagna Symposium on the Biology of Skin
          • Pemphigus & Pemphigoid
          • Progress in Translational Research
          • Psoriasis
          • Resources for Clinical Research in the JID
          • News
          • Society/Journal News
          • Advertisers
          • SID
          • SID Member Activation
          • SID Website
          • Join SID
          • Annual Meeting
          • Academic Industry Partnership
          • ESDR
          • ESDR Website
          • Join ESDR
          • Awards
          • Events
          • Media
          • Education
          • JAAD / JID Junction - NEW!
          • Companion Titles
          • Journal of Investigative Dermatology Symposium Proceedings
          • JID Innovations
          • Follow Us
          • Facebook
          • Twitter
          We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
          Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.

          • Privacy Policy  
          • Terms and Conditions  
          • Accessibility  
          • Help & Contact

          RELX